550 related articles for article (PubMed ID: 16917840)
1. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
[TBL] [Abstract][Full Text] [Related]
2. Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity.
de Oliveira DM; Barreto G; Galeano P; Romero JI; Holubiec MI; Badorrey MS; Capani F; Alvarez LD
Hum Exp Toxicol; 2011 Sep; 30(9):1382-91. PubMed ID: 21081703
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
4. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.
Shamoto-Nagai M; Maruyama W; Kato Y; Isobe K; Tanaka M; Naoi M; Osawa T
J Neurosci Res; 2003 Nov; 74(4):589-97. PubMed ID: 14598303
[TBL] [Abstract][Full Text] [Related]
5. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells.
Molina-Jiménez MF; Sánchez-Reus MI; Andres D; Cascales M; Benedi J
Brain Res; 2004 May; 1009(1-2):9-16. PubMed ID: 15120578
[TBL] [Abstract][Full Text] [Related]
7. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Nehru B; Verma R; Khanna P; Sharma SK
Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
[TBL] [Abstract][Full Text] [Related]
8. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
Schmidt WJ; Alam M
J Neural Transm Suppl; 2006; (70):273-6. PubMed ID: 17017541
[TBL] [Abstract][Full Text] [Related]
9. Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction in rotenone-induced PC12 cells.
Liu YM; Jiang B; Bao YM; An LJ
Toxicol In Vitro; 2008 Mar; 22(2):430-7. PubMed ID: 18082360
[TBL] [Abstract][Full Text] [Related]
10. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
11. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
[TBL] [Abstract][Full Text] [Related]
12. SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone.
Knaryan VH; Samantaray S; Park S; Azuma M; Inoue J; Banik NL
J Neurochem; 2014 Jul; 130(2):280-90. PubMed ID: 24341912
[TBL] [Abstract][Full Text] [Related]
13. Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells.
Naoi M; Yi H; Maruyama W; Inaba K; Shamoto-Nagai M; Akao Y; Gerlach M; Riederer P
Neurosci Lett; 2009 Nov; 465(2):118-22. PubMed ID: 19737600
[TBL] [Abstract][Full Text] [Related]
14. [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone].
Liu YY; Zhao HY; Zhao CL; Duan CL; Lu LL; Yang H
Sheng Li Xue Bao; 2006 Oct; 58(5):421-8. PubMed ID: 17041725
[TBL] [Abstract][Full Text] [Related]
15. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
Tai KK; Truong DD
J Neurosci Res; 2002 Aug; 69(4):559-66. PubMed ID: 12210849
[TBL] [Abstract][Full Text] [Related]
16. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
Watabe M; Nakaki T
J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
[TBL] [Abstract][Full Text] [Related]
17. Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease.
Kim S; Park SE; Sapkota K; Kim MK; Kim SJ
J Pharm Pharmacol; 2011 Oct; 63(10):1358-67. PubMed ID: 21899552
[TBL] [Abstract][Full Text] [Related]
18. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
Gu M; Iravani MM; Cooper JM; King D; Jenner P; Schapira AH
J Neurochem; 2004 Dec; 91(5):1075-81. PubMed ID: 15569251
[TBL] [Abstract][Full Text] [Related]
19. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.
Sun H; He X; Liu C; Li L; Zhou R; Jin T; Yue S; Feng D; Gong J; Sun J; Ji J; Xiang L
ACS Chem Neurosci; 2017 Jan; 8(1):155-164. PubMed ID: 27731637
[TBL] [Abstract][Full Text] [Related]
20. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
